Researchers examined discharge records of 2-to-18-year-old patients taken from from the Agency for Healthcare Research and Quality Kids’ Inpatient Database. They identified 8,527 pediatric hospitalizations with a C. diff diagnosis and 1.59 million discharges without C. diff.
The study shows attributable cost of C. diff occurring during a hospitalization ranged from $1,917 to $8,317, depending on whether model was adjusted for length of stay. When not adjusting for LOS, C. diff-associated hospitalizations cost 1.6 times more than non-C. diff associated hospitalizations. Attributable LOS of C. diff was approximately four days.
“Pediatric CDI cost analyses should account for LOS as an important confounder of cost,” study authors concluded.
More articles on infection control:
Top 10 infection control stories, Nov. 27 – Dec. 1
The art of brushing — ensuring clean medical devices to enhance patient safety
SHEA publishes infectious disease outbreak guidelines for hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
